Best pharmacist support for improving palliative care from early to end of life

2021 Fiscal Year Final Research Report

• Project/Area Number: 19K10546
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 58010:Medical management and medical sociology-related
• Research Institution: Kyoto Pharmaceutical University
• Principal Investigator: Chikako Matsumura 京都薬科大学, 薬学部, 講師 (00549305)
• Co-Investigator(Kenkyū-buntansha): 矢野 義孝 京都薬科大学, 薬学部, 教授 (60437241)
• Project Period (FY): 2019-04-01 – 2022-03-31
• Keywords: 緩和医療 / QOL / がん疼痛 / 薬剤師外来

Outline of Final Research Achievements

Best pharmacist support was established to improve patient satisfaction and patient quality of life (QOL) by relieving physical pain from early to end of life.The overall QOL score of patient-reported outcomes in outpatients with cancer pain was significantly correlated with the daily maximum pain score, indicating that relief of the maximum pain improves patient QOL.In addition, our result that the agreement between patient-reported outcomes scores and symptom ratings scores by health care providers in terminal cancer patients indicated that health care providers tended to underestimate overall subjective distress symptoms, including fatigue. The results indicate the importance of symptom ratings in consideration with patient-reported outcomes.

Free Research Field

医療薬学

Academic Significance and Societal Importance of the Research Achievements

がん疼痛患者における適切な薬学的支援方法については未だ明確になっておらず、患者は十分なケアを享受できていないのが現状である。そこで外来がん疼痛患者の包括的な緩和ケア方法を構築すること、また終末期がん患者の症状評価における支援方法を確立させることは非常に重要である。
本研究成果である、がん疼痛患者における最適な薬学的支援方法および終末期がん患者の患者報告アウトカムを加味した症状評価は緩和ケアの質の向上に貢献することが期待できる。